Practical considerations for treating patients with cancer in the COVID-19 pandemic

Simple item page
dc.contributor.authorSegelov, Eva
dc.contributor.authorUnderhill, Craig
dc.contributor.authorPrenen, Hans
dc.contributor.authorKarapetis, C S
dc.contributor.authorJackson, Christopher
dc.contributor.authorNott, Louise M
dc.contributor.authorClay, Tim
dc.contributor.authorPavlakis, Nick
dc.contributor.authorSabesan, Sabe
dc.contributor.authorHeywood, Ellen
dc.contributor.authorYip, Desmond
dc.date.accessioned2023-02-01T22:39:49Z
dc.date.issued2020
dc.date.updated2021-12-02T05:02:00Z
dc.description.abstractCancer has become a prevalent disease, affecting millions of new patients globally each year. The COVID-19 pandemic is having far-reaching impacts around the world, causing substantial disruptions to health and health care systems that are likely to last for a prolonged period. Early data have suggested that having cancer is a significant risk factor for mortality from severe COVID-19. A diverse group of medical oncologists met to formulate detailed practical advice on systemic anticancer treatments during this crisis. In the context of broad principles, issues including risks of treatment, principles of prioritizing resources, treatment of elderly patients, and psychosocial impact are discussed. Detailed treatment advice and options are given at a tumor stream level. We must maintain care for patients with cancer as best we can and recognize that COVID-19 poses a significant competing risk for death that changes conventional treatment paradigms.en_AU
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn0277-3732en_AU
dc.identifier.urihttp://hdl.handle.net/1885/284115
dc.language.isoen_AUen_AU
dc.publisherLippincott Williams & Wilkins Ltd.en_AU
dc.rights© 2020 by American Society of Clinical Oncologyen_AU
dc.sourceAmerican Journal of Clinical Oncologyen_AU
dc.titlePractical considerations for treating patients with cancer in the COVID-19 pandemicen_AU
dc.typeJournal articleen_AU
local.bibliographicCitation.issue8en_AU
local.bibliographicCitation.lastpage482en_AU
local.bibliographicCitation.startpage467en_AU
local.contributor.affiliationSegelov, Eva, Monash Universityen_AU
local.contributor.affiliationUnderhill, Craig, Border Medical Oncologyen_AU
local.contributor.affiliationPrenen, Hans, Department of Oncology, University Hospital Antwerpen_AU
local.contributor.affiliationKarapetis, C S, Flinders Universityen_AU
local.contributor.affiliationJackson, Christopher, Department of Medical Oncology, Flinders Universityen_AU
local.contributor.affiliationNott, Louise M, Royal Hobart Hospital Department of Medical Oncology Hobarten_AU
local.contributor.affiliationClay, Tim, St John of God Subiaco Hospital, Edith Cowan Universityen_AU
local.contributor.affiliationPavlakis, Nick, Royal North Shore Hospitalen_AU
local.contributor.affiliationSabesan, Sabe, Townsville Clinical Schoolen_AU
local.contributor.affiliationHeywood, Ellen, Cancer Services, Monash Healthen_AU
local.contributor.affiliationYip, Desmond, College of Health and Medicine, ANUen_AU
local.contributor.authoremailu5086006@anu.edu.auen_AU
local.contributor.authoruidYip, Desmond, u5086006en_AU
local.description.embargo2099-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor321104 - Cancer therapy (excl. chemotherapy and radiation therapy)en_AU
local.identifier.absfor320700 - Medical microbiologyen_AU
local.identifier.absfor321105 - Chemotherapyen_AU
local.identifier.ariespublicationa383154xPUB14103en_AU
local.identifier.citationvolume16en_AU
local.identifier.doi10.1200/OP.20.00229en_AU
local.identifier.scopusID2-s2.0-85089407056
local.identifier.uidSubmittedBya383154en_AU
local.publisher.urlhttps://ascopubs.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
op.20.00229.pdf
Size:
763.3 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

ANU Research Publications

DSpace software copyright © 2002-2024 LYRASIS